Evolution of Megakaryocyte Abnormalities in the Progression of Primary Myelofibrosis


The Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow (2021-Present)

Johanna Melo-Cardenas, PhD, St. Jude Children’s Research Hospital

Dr. Melo-Cardenas has been awarded a grant focused on studying alterations in large cells in the bone marrow called megakaryocytes, and exploring how changes in the bone marrow microenvironment contribute to disease progression in primary myelofibrosis, a blood cancer characterized by a buildup of fibrous tissue that impairs the bone marrow’s ability to produce normal blood cells.

Content courtesy of Leukemia & Lymphoma Society

BACK TO OUR PORTFOLIO